• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hepatitis B reactivation in patients receiving immunosuppressive therapy: a hidden menace.

作者信息

Lin Chih-Lin, Kao Jia-Horng

机构信息

Department of Gastroenterology, Renai Branch, Taipei City Hospital, Taipei, Taiwan.

Department of Psychology, National Chengchi University, Taipei, Taiwan.

出版信息

Hepatol Int. 2017 Jan;11(1):31-33. doi: 10.1007/s12072-016-9782-x. Epub 2017 Jan 5.

DOI:10.1007/s12072-016-9782-x
PMID:28058576
Abstract
摘要

相似文献

1
Hepatitis B reactivation in patients receiving immunosuppressive therapy: a hidden menace.接受免疫抑制治疗患者的乙型肝炎再激活：一种潜在威胁。
Hepatol Int. 2017 Jan;11(1):31-33. doi: 10.1007/s12072-016-9782-x. Epub 2017 Jan 5.
2
HBV reactivation risk factors in patients with chronic HBV infection with low replicative state and resolved HBV infection undergoing hematopoietic stem cell transplantation in Korea.韩国慢性乙型肝炎病毒（HBV）低复制状态感染者及HBV感染已康复者接受造血干细胞移植时的HBV再激活危险因素
Hepatol Int. 2017 Jan;11(1):87-95. doi: 10.1007/s12072-016-9747-0. Epub 2016 Jun 28.
3
Reactivation of resolved hepatitis B virus infection after immunosuppression: is it time to adopt pre-emptive therapy?免疫抑制后已解决的乙型肝炎病毒感染再激活：是否是时候采用抢先治疗？
Clin Res Hepatol Gastroenterol. 2012 Feb;36(1):84-93. doi: 10.1016/j.clinre.2011.07.018. Epub 2011 Sep 14.
4
Nationwide prospective and retrospective surveys for hepatitis B virus reactivation during immunosuppressive therapies.全国范围内针对免疫抑制治疗期间乙型肝炎病毒再激活的前瞻性和回顾性调查。
J Gastroenterol. 2016 Oct;51(10):999-1010. doi: 10.1007/s00535-016-1168-2. Epub 2016 Feb 1.
5
Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression.乙型肝炎表面抗原的遗传元件对于免疫逃逸至关重要，与免疫抑制后乙型肝炎病毒的再激活相关。
Hepatology. 2015 Mar;61(3):823-33. doi: 10.1002/hep.27604. Epub 2015 Jan 28.
6
Efficacy of antiviral prophylaxis in HBsAg-negative, anti-HBc positive patients undergoing hematopoietic stem cell transplantation.抗病毒预防对接受造血干细胞移植的HBsAg阴性、抗HBc阳性患者的疗效。
Liver Int. 2015 Dec;35(12):2530-6. doi: 10.1111/liv.12882. Epub 2015 Jun 19.
7
Hepatitis B re-activation with rituximab therapy: treat the patient not the disease.利妥昔单抗治疗引发的乙型肝炎再激活：治疗患者而非疾病。
Liver Int. 2011 Mar;31(3):277-9. doi: 10.1111/j.1478-3231.2011.02452.x. Epub 2011 Jan 25.
8
[Immunosuppressive therapy for hepatitis B virus reactivation].[乙型肝炎病毒再激活的免疫抑制治疗]
Zhonghua Nei Ke Za Zhi. 2006 Jun;45(6):443-4.
9
[Hepatitis B reactivation following immunosuppressive therapy and screening adherence: a neglected problem?].[免疫抑制治疗后乙肝再激活与筛查依从性：一个被忽视的问题？]
Dtsch Med Wochenschr. 2012 Jul;137(28-29):1458-62. doi: 10.1055/s-0032-1305102. Epub 2012 Jul 3.
10
Prevention of Hepatitis B reactivation in the setting of immunosuppression.免疫抑制情况下乙肝再激活的预防。
Clin Mol Hepatol. 2016 Jun;22(2):219-37. doi: 10.3350/cmh.2016.0024. Epub 2016 Jun 13.

引用本文的文献

1
APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation.APASL HCV 指南：DAA 治愈的 HCV 患者应如何监测 HCC 发生和 HBV 再激活。
Hepatol Int. 2019 Nov;13(6):649-661. doi: 10.1007/s12072-019-09988-7. Epub 2019 Sep 20.
2
A Rare Case of Pembrolizumab-Induced Reactivation of Hepatitis B.帕博利珠单抗诱发乙型肝炎再激活的罕见病例。
Case Rep Oncol Med. 2018 Oct 17;2018:5985131. doi: 10.1155/2018/5985131. eCollection 2018.

本文引用的文献

1
New perspectives of biomarkers for the management of chronic hepatitis B.慢性乙型肝炎管理中生物标志物的新视角
Clin Mol Hepatol. 2016 Dec;22(4):423-431. doi: 10.3350/cmh.2016.0069. Epub 2016 Dec 25.
2
Association of Hepatitis B Core-Related Antigen With Hepatitis B Virus Reactivation in Occult Viral Carriers Undergoing High-Risk Immunosuppressive Therapy.乙肝核心相关抗原与接受高风险免疫抑制治疗的隐匿性病毒携带者中乙肝病毒再激活的关联
Am J Gastroenterol. 2016 Dec;111(12):1788-1795. doi: 10.1038/ajg.2016.436. Epub 2016 Sep 20.
3
HBV reactivation risk factors in patients with chronic HBV infection with low replicative state and resolved HBV infection undergoing hematopoietic stem cell transplantation in Korea.
韩国慢性乙型肝炎病毒（HBV）低复制状态感染者及HBV感染已康复者接受造血干细胞移植时的HBV再激活危险因素
Hepatol Int. 2017 Jan;11(1):87-95. doi: 10.1007/s12072-016-9747-0. Epub 2016 Jun 28.
4
Human Cytokine Genetic Variants Associated With HBsAg Reverse Seroconversion in Rituximab-Treated Non-Hodgkin Lymphoma Patients.与利妥昔单抗治疗的非霍奇金淋巴瘤患者HBsAg血清学逆转相关的人类细胞因子基因变异
Medicine (Baltimore). 2016 Mar;95(11):e3064. doi: 10.1097/MD.0000000000003064.
5
Looking into the crystal ball: biomarkers for outcomes of HBV infection.展望未来：乙肝病毒感染预后的生物标志物
Hepatol Int. 2016 Jan;10(1):99-101. doi: 10.1007/s12072-015-9698-x. Epub 2016 Jan 5.
6
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.《亚太地区乙型肝炎管理临床实践指南：2015年更新版》
Hepatol Int. 2016 Jan;10(1):1-98. doi: 10.1007/s12072-015-9675-4. Epub 2015 Nov 13.
7
Perspectives and control of hepatitis B virus infection in Taiwan.台湾地区乙肝病毒感染的现状与防控
J Formos Med Assoc. 2015 Oct;114(10):901-9. doi: 10.1016/j.jfma.2015.06.003. Epub 2015 Jul 13.
8
Prevention of acute exacerbation of chronic hepatitis B infection in cancer patients receiving chemotherapy in a hepatitis B virus endemic area.在乙型肝炎病毒流行地区，接受化疗的癌症患者中预防慢性乙型肝炎感染的急性加重。
Hepatology. 2015 Aug;62(2):387-96. doi: 10.1002/hep.27843. Epub 2015 Jun 3.
9
Slow decline of hepatitis B burden in general population: Results from a population-based survey and longitudinal follow-up study in Taiwan.乙型肝炎负担在一般人群中缓慢下降：来自台湾基于人群的调查和纵向随访研究的结果。
J Hepatol. 2015 Aug;63(2):354-63. doi: 10.1016/j.jhep.2015.03.013. Epub 2015 Mar 17.
10
Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective study.曾感染乙型肝炎病毒的淋巴瘤患者接受含利妥昔单抗化疗后乙型肝炎病毒再激活：一项前瞻性研究。
J Clin Oncol. 2014 Nov 20;32(33):3736-43. doi: 10.1200/JCO.2014.56.7081. Epub 2014 Oct 6.